7th December 2020
We’re excited to announce an enhanced interpretation of our popular HypoxyLab™ hypoxia workstation.
Externally nothing changes. The HypoxyLab remains just as uniquely compact and ergonomically shaped as it always has been.
Internally however, we have implemented a complete redesign of the turret/shelf structure that houses the gas distribution system, temperature regulation, sensors and HEPA filter, resulting in an almost 50% increase in working volume coupled with improved sample evaporation characteristics, easy HEPA filter serviceability, ergonomic shelving and a markedly reduced noise footprint.
The additional working volume and sense of spaciousness is dramatic. Commenting on his experience with the new system, Prof. Oliver Thews (an existing HypoxyLab user at the Martin-Luther University in Halle-Wittenberg, Germany) commented, “The new design offers so much more space for the experiments in the chamber. Even larger measurement devices can [now] be used inside. I was impressed by how fast the chamber reaches new atmospheric compositions, which allows for more rapid oxygenation profiles.”
The HypoxyLab™ is a bench-top hypoxia workstation for cell biologists that require an ability to mimic the true in vivo oxygen state during cell culture.
The enhanced model will ship beginning January 2021.
22nd December 2020
A year like no other
7th December 2020
HypoxyLab™: You spoke. We listened
2nd June 2020
Customer Spotlight
22nd April 2020
Oxford Optronix builds 2000 Flo-Ox™ monitors in 8 days!
8th April 2020
Oxford Optronix receives MHRA waiver and begins volume manufacture of Oxygen Monitors for CPAP
30th March 2020
Oxford Optronix develops an oxygen monitor in 5 DAYS in emergency COVID-19 response call
16th March 2020
Business continuity statement / COVID-19 pandemic
6th January 2020
Here comes 2020
11th April 2019
WellBeing™ clinical trials commence
5th February 2019
Article highlight
2nd January 2019
Happy New Year!
30th October 2018
Oxygenation in cell culture: Critical parameters for reproducibility routinely go unreported
11th June 2018
Oxford Optronix in South America. Guest post by Petra Mayr, International Product Manager
12th April 2018
Announcing our Live Webinar: Measuring Tissue Perfusion and pO2 to Investigate Organ Failure
12th February 2018
Oxford Optronix expands Australia/New Zealand market reach through distribution agreement with APAC Scientific
31st January 2018
Oxford Optronix Ltd. and Scintica Instrumentation Inc. join forces for product distribution in North America
20th December 2017
Oxford Optronix achieves accreditation to the latest medical devices standard
16th October 2017
Ed Vaizey MP visits Oxford Optronix
2nd June 2017
Welcome to our new website!
12th May 2017
Spring has sprung
1st December 2016
Reflecting on 2016; looking forward to 2017
1st October 2016
A little time Down Under…
1st July 2016
Refreshed product warranty packages for OxyLite and OxyFlo
1st April 2016
Latest GelCount software update
1st February 2016
Guest post by John Coyle, Business Development Principle
1st January 2016
Announcing a mutual distribution deal with Baker Ruskinn
1st December 2015
Asia distributor workshop
1st June 2015
Performance updates for HypoxyLab
1st March 2015
Meet us at Genes & Cancer UK, Cambridge
1st January 2015
Looking forward to a busy 2015
1st November 2014
Oxford Optronix reaches new customers
1st July 2014
Data acquisition and recording just got a whole lot easier!
1st April 2014
Guest post by Michael Rau, Director of Sales
1st March 2014
Strategic tie-up with SciPro Inc., USA
1st February 2014
Single-channel OxyFlo™ now shipping
1st January 2014
GelCount™ software update
1st December 2013
Reflections on 2013
1st November 2013
Autumn conference round-up
1st October 2013
Our 2013 Customer Survey results are out
1st July 2013
Announcing our newly commissioned cleanroom
1st June 2013
A report on conferences attended in 2013 so far
1st April 2013
Presenting HypoxyLab™ - a benchtop, HEPA-filtered hypoxia workstation
1st February 2013
Next-generation OxyLite™ and OxyFlo™ monitors
1st January 2013
Oxford Optronix Ltd. receives grant from The Health Innovation Challenge Fund.